What is a villous adenoma polyp?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is a Villous Adenoma Polyp?

A villous adenoma is a type of precancerous (neoplastic) colorectal polyp characterized by finger-like projections (villi) of glandular tissue, which carries a significantly higher risk of malignant transformation compared to other adenoma types.

Classification and Histologic Features

Villous adenomas are classified based on their architectural pattern 1:

  • Pure villous adenoma: >80% of the polyp contains villous (finger-like) elements
  • Tubulovillous adenoma: Mixed architecture where neither tubular nor villous elements exceed 80%
  • Tubular adenoma: >80% tubular elements (lowest malignant potential)

The villous architecture consists of elongated, finger-like projections lined by dysplastic glandular epithelium 2. These polyps typically appear as soft, velvety, sessile (flat-based) masses with a characteristic glossy or shaggy surface 3.

Malignant Potential and Clinical Significance

Villous adenomas have the highest cancer risk among adenomatous polyps, with malignancy rates reaching 33-50% in large lesions 3, 4:

  • Size-dependent risk: Polyps >2 cm carry up to 50% malignancy risk 3
  • Giant villous adenomas (>8 cm): Combined dysplasia/malignancy risk approaches 83% 3
  • Even smaller villous adenomas show higher rates of severe dysplasia compared to tubular adenomas 4

The cancer develops when dysplastic changes penetrate through the muscularis mucosae into deeper tissue layers 5.

Current Guideline Perspective on Villous Histology

Importantly, recent UK guidelines (2020) have deliberately excluded villous/tubulovillous histology from their surveillance algorithms 1. The rationale:

  • Poor inter-observer agreement among pathologists in assessing villous architecture
  • Lack of evidence that villous histology independently predicts long-term colorectal cancer risk in surveillance populations
  • Concerns about generating excessive surveillance workload

However, international definitions of "advanced adenoma" traditionally include villous features 6, 7, though UK guidelines define advanced adenomas solely by size (≥10 mm) or high-grade dysplasia 1.

Clinical Presentation

Villous adenomas commonly present with:

  • Rectal bleeding (most common)
  • Mucus discharge (characteristic feature due to mucin-secreting cells)
  • Electrolyte disturbances in large lesions (water and electrolyte loss) 2
  • Often asymptomatic until reaching substantial size

Location and Demographics

  • Most frequent in distal colon: Sigmoid colon and rectum 4
  • Predominantly affects older adults: Peak incidence in 6th-7th decades 3
  • Often associated with chronic irritation, though this is more relevant for rare extracolonic sites 8

Management Implications

Complete excision is essential given the high malignancy risk 5, 3:

  • Small pedunculated lesions: Endoscopic polypectomy may suffice
  • Large sessile/circumferential lesions: Often require surgical resection (laparoscopic or open) as they exceed endoscopic removal capabilities 3
  • Incomplete endoscopic removal: Warrants site-check colonoscopy within 2-6 months 1

After complete removal of villous adenomas without invasive cancer, patients typically require surveillance colonoscopy, though specific intervals depend on overall polyp burden and other risk factors per current guidelines 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.